Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19
Status:
Completed
Trial end date:
2020-09-02
Target enrollment:
Participant gender:
Summary
Phase 2:
The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative
to the control arm in adult patients hospitalized with COVID-19 regardless of disease
severity strata.
Phase 3 Cohort 1:
The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative
to the control arm in adult patients hospitalized with critical COVID-19 receiving mechanical
ventilation at baseline.
Phase 3 Cohort 2:
The primary objective of the study is to evaluate the clinical efficacy of sarilumab relative
to the control arm in adult patients hospitalized with COVID-19 receiving mechanical
ventilation at baseline.